Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Laetsch TW, Maude SL, Rives S, Hiramatsu H, Bittencourt H, Bader P, Baruchel A, Boyer M, de Moerloose B, Qayed M, et al. Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial. J Clin Oncol. 2022:JCO2200642.
Agrawal P, Nordli DR, McLendon LA. A three-year-old with central nervous system graft versus host disease: A rare cause of posthematopoietic stem cell transplant encephalopathy. Pediatr Blood Cancer. 2023:e30307.
Li N-Z, Wang Z-X, Zhang F, Feng C-Z, Chen Y, Liu D-J, Chen S-B, Jin Y, Zhang Y-L, Xie Y-Y, et al. Threonine dehydrogenase regulates neutrophil homeostasis but not H3K4me3 levels in zebrafish. FEBS J. 2024.
Wu X, Yuan H, Wu Q, Gao Y, Duan T, Yang K, Huang T, Wang S, Yuan F, Lee D, et al. Threonine fuels glioblastoma through YRDC-mediated codon-biased translational reprogramming. Nat Cancer. 2024.
Chen G, Wang J. Threonine metabolism and embryonic stem cell self-renewal. Curr Opin Clin Nutr Metab Care. 2013.
d'Audigier C, Cochain C, Rossi E, Guérin CL, Bieche I, Blandinières A, Marsac B, Silvestre J-S, Gaussem P, Smadja DM. Thrombin receptor PAR-1 activation on endothelial progenitor cells enhances chemotaxis-associated genes expression and leukocyte recruitment by a COX-2-dependent mechanism. Angiogenesis. 2015.
Vijayakumar A, Tiwari R, Prabhuswamy VKumar. Thromboangiitis Obliterans (Buerger's Disease)-Current Practices. Int J Inflam. 2013;2013:156905.
Anthon CThomas, Pène F, Perner A, Azoulay E, Puxty K, Van De Louw A, Barratt-Due A, Chawla S, Castro P, Póvoa P, et al. Thrombocytopenia and platelet transfusions in ICU patients: an international inception cohort study (PLOT-ICU). Intensive Care Med. 2023.
Pelland-Marcotte M-C, Pole JD, Kulkarni K, Athale U, Stammers D, Sabapathy C, Halparin J, Brandão LR, Sung L. Thromboembolism Incidence and Risk Factors in Children with Cancer: A Population-Based Cohort Study. Thromb Haemost. 2018.
Ikezoe T, Yang J, Nishioka C, Umezawa K, Yokoyama A. Thrombomodulin blocks calcineurin inhibitor-induced vascular permeability via inhibition of Src/VE-cadherin axis. Bone Marrow Transplant. 2016.
Al-Samkari H. Thrombopoietin Agonism to Promote Platelet Engraftment Following Hematopoietic Stem Cell Transplantation: Promising, but Not Ready for Primetime. Transplant Cell Ther. 2024;30(5):465-467.
Takeshita S, Kakita H, Nakamura N, Mori M, Toriuchi K, Aoki H, Inoue Y, Hayashi H, Yamada Y, Aoyama M. Thrombopoietin exerts a neuroprotective effect by inhibiting the suppression of neuronal proliferation and axonal outgrowth in intrauterine growth restriction rats. Exp Neurol. 2024:114781.
Spivak JL, Merchant A, Williams DM, Rogers O, Zhao W, Duffield A, Resar LS, Moliterno AR, Zhao ZJ. Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia vera. PLoS One. 2020;15(6):e0232801.
Fu H, Lv M, Liu H, Sun Y, Zhang Y, Mo X, Han T, Wang F, Yan C, Wang Y, et al. Thrombopoietin level predicts the response to avatrombopag treatment for persistent thrombocytopenia after haploidentical haematopoietic stem cell transplantation. Bone Marrow Transplant. 2023.
Nakamura-Ishizu A, Matsumura T, Stumpf PS, Umemoto T, Takizawa H, Takihara Y, O'Neil A, Majeed A'QBanu Bte A, Macarthur BD, Suda T. Thrombopoietin Metabolically Primes Hematopoietic Stem Cells to Megakaryocyte-Lineage Differentiation. Cell Rep. 2018;25(7):1772-1785.e6.
Vercellino J, Małachowska B, Kulkarni S, Bell BI, Shajahan S, Shinoda K, Eichenbaum G, Verma AK, Ghosh SP, Yang W-L, et al. Thrombopoietin mimetic stimulates bone marrow vascular and stromal niches to mitigate acute radiation syndrome. Stem Cell Res Ther. 2024;15(1):123.
van der Garde M, van Hensbergen Y, Brand A, Slot MC, de Graaf-Dijkstra A, Mulder A, Watt SM, Zwaginga JJan. Thrombopoietin treatment of one graft in a double cord blood transplant provides early platelet recovery while contributing to long term engraftment in NSG mice. Stem Cells Dev. 2014.
Zou H, Wong RSM, Yan X. Thrombopoietin treats erythropoietin resistance by correcting EPO-induced progenitorcell depletion. Biochem Pharmacol. 2023:116008.
Wiegering V, Schmid S, Andres O, Wirth C, Wiegering A, Meyer T, Winkler B, Schlegel PG, Eyrich M. Thrombosis as a complication of central venous access in pediatric patients with malignancies: a 5-year single-center experience. BMC Hematol. 2014;14(1):18.
Olivi M, Di Biase F, Lanzarone G, Arrigo G, Martella F, Apolito V, Secreto C, Freilone R, Bruno B, Audisio E, et al. Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges. Curr Treat Options Oncol. 2023.
Pei L, Ouyang Z, Zhang H, Huang S, Jiang R, Liu B, Tang Y, Feng M, Yuan M, Wang H, et al. Thrombospondin 1 and Reelin act through Vldlr to regulate cardiac growth and repair. Basic Res Cardiol. 2023.
Niu J, Liu Y, Wang J, Wang H, Zhao Y, Zhang M. Thrombospondin-2 acts as a critical regulator of cartilage regeneration: A review. Medicine (Baltimore). 2023;102(17):e33651.
Niu J, Feng F, Zhang S, Zhu Y, Song R, Li J, Zhao L, Wang H, Zhao Y, Zhang M. Thrombospondin-2 Couples Pressure-Promoted Chondrogenesis through NF-κB Signaling. Tissue Eng Regen Med. 2023.
Alford AI, Hankenson KD. Thrombospondins modulate cell function and tissue structure in the skeleton. Semin Cell Dev Biol. 2023.
Nusrat S, Davis H, MacDougall K, George JN, Nakamura R, Borogovac A. Thrombotic Microangiopathy After Hematopoietic Stem Cell and Solid Organ Transplantation: A Review for Intensive Care Physicians. J Intensive Care Med. 2023:8850666231200193.